LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3 asthma patients Sunny Jabbal (Dundee, United Kingdom), Sunny Jabbal, Arvind Manoharan, William Anderson, Joseph Lipworth, Brian Lipworth
| |
LATE-BREAKING ABSTRACT: The benefits of [italic]Nigella sativa[/italic] oil supplementation on asthma inflammation: A randomised, double-blind, placebo-controlled, phase II trial Abdulrahman Koshak (London, United Kingdom), Abdulrahman Koshak, Li Wei, Emad Koshak, Siraj Wali, Omer Alamoudi, Abdulrahman Demerdash, Majdy Qutub, Peter Pushparaj, Michael Heinrich
| |
LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study Massimo Corradi (Parma, Italy), Massimo Corradi, Monica Spinola, Alessandro Guasconi, Géraldine Cohuet, Isabella Montagna, Andrea Bizzi, Stefano Petruzzelli
| |
LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results Eugene R. Bleecker (Winston-Salem, United States of America), Eugene Bleecker, J. Mark FitzGerald, Pascal Chanez, Alberto Papi, Steve Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoria Werkström, Mitchell Goldman
| |
LATE-BREAKING ABSTRACT: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA therapy: The FLAME study Wisia Wedzicha (London, United Kingdom), Jadwiga Wedzicha, Karen Mezzi, Tim Ayers, Chau Thach, Robert Fogel, Francesco Patalano, Donald Banerji
| |
LATE-BREAKING ABSTRACT: Pulmonary deposition of a novel LAMA/LABA Co-Suspension[sup][trade][/sup] technology glycopyrronium/formoterol (GFF) MDI in healthy subjects (PT003020) Sarvajna Dwivedi (Redwood City, United States of America), Glyn Taylor, Simon Warren, Chad Orevillo, Andrea Maes, Ubaldo J. Martin, Sarvajna Dwivedi, Colin Reisner
| |
LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study Siva Mahendran (Watford, United Kingdom), Siva Mahendran, Rosemary Ebling, Mohammad Ibrahim, Tariq Sethi
| |
LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD Nausherwan Burki (Farmington, United States of America), Nausherwan Burki, Marsden Granger, Debapriya Datta
| |